No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Jubilant Ingrevia Limited, established in 2019 and headquartered in Noida, India, is a global provider of life science products and specialized solutions. The company, which operated as Jubilant LSI Limited until its rebranding in October 2020, conducts its operations through three main divisions. The Specialty Chemicals segment offers pyridine and picoline derivatives, various fine chemicals, crop protection compounds, and comprehensive custom development and manufacturing (CDMO) services. Its Nutrition & Health Solutions division supplies a wide array of ingredients and formulations catering to both animal and human health and dietary needs, including essential vitamins like B3 and B4, picolinates, riboflavin phosphate sodium, and nutritional premixes. The Chemical Intermediates segment produces key industrial components such as acetyl-based chemicals and specialty ethanol, alongside products like acetic anhydride, acetic acid, and ethyl acetate. Jubilant Ingrevia's expansive portfolio also features other pyridine derivatives (e.g., cyanopyridines, piperidines), metal complexes, antioxidants, and specialized feed additives such as mineral premixes, amino acids, herbal choline, and growth enhancers. The company's services encompass route design, process optimization, and large-scale manufacturing of intermediates. It serves a diverse clientele across pharmaceutical, animal and human nutrition, agrochemical, personal and consumer care, and general industrial sectors.
jubilantingrevia.comNo one on the platform currently holds JUBLINGREA.BO.
No tracked institution reports a position in JUBLINGREA.BO as of their last filing.
No one on the platform has traded JUBLINGREA.BO yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 7.9% | 10.1% | — | — | — | |
| Rev. Growth % | 6.4% | 45.2% | ||||
| Profit Margin % | 6.3% | 6.6% | ||||
| Free Cash Flow Margin % | 3.7% | 1.6% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $52.7B | +19.3% | $27.07 | $23.94–$31.81 | — | 6 |
| 2028 | $59.2B | +12.3% | $31.72 | $24.13–$36.83 | — | 7 |
| 2029 | $65.8B | +11.2% | $34.33 | $33.90–$34.77 | — | 2 |
| 2030 | $80.3B | +22.1% | $45.30 | $39.55–$49.58 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 7 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-07-22 | $6.70 | $6.70 | +0.0% |
| 2026-05-26 | $4.35 | $5.50 | +26.4% |
| 2026-02-04 | $3.50 | $3.60 | +2.9% |
| 2025-10-27 | $4.05 | $4.40 | +8.6% |
| 2025-07-31 | $4.50 | $4.80 | +6.7% |
| 2025-05-13 | $4.50 | $4.70 | +4.4% |
| 2025-01-28 | $2.00 | $4.40 | +120.0% |
| 2024-10-22 | $4.00 |
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| JUBLINGREA.BOJubilant Ingrevia Limited | $630.00 | -4.42% | $99.5B | — |
| AETHER.BOAether Industries Limited | $1590.30 | -5.40% | $211.2B | — |
| AETHER.NSAether Industries Limited | $1597.20 | +0.89% | $212.0B | — |
| ALKYLAMINE.BOAlkyl Amines Chemicals Limited | $1775.25 | -4.92% | $90.8B | — |
| ANURAS.BOAnupam Rasayan India Limited |
| $3.70 |
| -7.5% |
| $1166.85 |
| -4.31% |
| $132.6B |
| — |
| ANURAS.NSAnupam Rasayan India Limited | $1179.80 | +0.80% | $134.3B | — |
| CLEAN.BOClean Science and Technology Limited | $820.30 | -3.27% | $87.1B | — |
Source: Financial Modeling Prep · peers by sector/industry